Edwards Lifesciences Net Cash Flow or Change in Cash and Cash Equivalents Trend

EW -- USA Stock  

USD 137.87  0.74  0.54%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Net Cash Flow or Change in Cash and Cash Equivalents of Edwards Lifesciences Corporation with missing and latest data points interpolated. Principal component of the cash flow statement representing the amount of increase (decrease) in cash and cash equivalents. Includes Net Cash Flow from Operations
Net Cash Flow or Change in Cash and Cash Equivalents10 Years Trend
Increasing
Slightly volatile
 Net Cash Flow or Change in Cash and Cash Equivalents 
      Timeline 

Regression Statistics

Arithmetic Mean  97,085,088
Coefficient Of Variation  124.95
Mean Deviation  81,204,240
Median  115,400,000
Standard Deviation  121,306,858
Range  458,300,000
R Value  0.48
R Squared  0.23
Significance  0.11
Slope  16,185,425

Edwards Lifesciences Net Cash Flow or Change in Cash and Cash Equivalents Over Time

2016-12-31  211,700,000 
2017-12-31  211,700,000 
2018-12-31  145,421,053 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

Edwards Lifesciences Upcoming Company Events
Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.